A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder
Bhattacharyya, Madhumita, Ph.D., M.R.C.P, Powles, Tom, M.D., M.R.C.P, Mutsvangwa, Katherine, Wilson, Peter, B.Ed, Oliver, Timothy, M.D., F.R.C.P, Shamash, Jonathan, M.D., F.R.C.P
Published in Urologic oncology (01.08.2013)
Published in Urologic oncology (01.08.2013)
Get full text
Journal Article